Denosumab biosimilar by Lupin for Post Menopausal Osteoporosis: Likelihood of Approval

Denosumab biosimilar is under clinical development by Lupin and currently in Phase III for Post Menopausal Osteoporosis.

Source link
#Denosumab #biosimilar #Lupin #Post #Menopausal #Osteoporosis #Likelihood #Approval